Success Metrics

Clinical Success Rate

75.0%

Based on 3 completed trials

Completion Rate

75%(3/4)

Active Trials

1(14%)

Results Posted

33%(1 trials)

Terminated

1(14%)

Phase Distribution

Ph not_applicable

100%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution7 total trials

N/ANon-phased studies

7(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(3)

Terminated(1)

Other(2)

Detailed Status

Completed3

unknown2

Terminated1

Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

75.0%

Most Advanced

N/A

Trials by Phase

N/A7 (100.0%)

Trials by Status

terminated114%

active_not_recruiting114%

unknown229%

completed343%

Recent Activity

1 active trials

Showing 5 of 7

completednot_applicable

Clinical Trials (7)

Showing 7 of 7 trials

NCT06305481Not Applicable

Glaucoma Evaluation With the P200TE

Completed

NCT05844852Not Applicable

P200TE US Reference Database Study

Active Not Recruiting

NCT05624593Not Applicable

P200TE and Predicate Agreement and Precision Study

Unknown

NCT05536401Not Applicable

P200TE Agreement and Precision Study

Terminated

NCT03912584Not Applicable

Study Comparing the P200TE and the P200TxE in Glaucoma Patients

Completed

NCT03783858Not Applicable

Image Collection of Normal Eyes for Development of an EU RDB

Completed

NCT02921568Not Applicable

Side-by-Side Comparison of P200TE and Spectral OCT/SLO on Diseased Eyes

Unknown

All 7 trials loaded

Drug Details

Intervention Type: DEVICE
Total Trials: 7